Advertisement

Ads Placeholder
Loading...

Eastgate Biotech Corp.

ETBI•PNK
Healthcare
Medical - Pharmaceuticals
$0.001
$0.00(0.00%)
U.S. Market opens in 50h 44m

Eastgate Biotech Corp. (ETBI) Stock Overview

Explore Eastgate Biotech Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.1M
P/E Ratio-0.54
EPS (TTM)$-0.01
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

ETBI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Eastgate Biotech Corp. (ETBI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.54 and a market capitalization of 2.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-66.67%
6-Month Change
-66.67%
Year-to-Date (YTD) Change
-66.67%
1-Year Change
99900.00%
3-Year Change
900.00%
5-Year Change
-71.43%
All-Time (Max) Change
-99.60%

Contact Information

www.EastGateBiotech.com
647-692-0652
65 Harbour Square Suite 2203Toronto, M5J 2L4Canada, Toronto, NV, NaN

Company Facts

20 Employees
IPO DateMar 5, 2014
CountryUS
Actively Trading

Frequently Asked Questions